Do NOT Stop Warfarin for Dental Extraction in This High-Risk Patient
For a patient on warfarin for valvular AF with mitral stenosis and mitral regurgitation requiring dental extraction, warfarin should be CONTINUED without interruption, provided the INR is within therapeutic range (2.0-3.0) and checked within one week before the procedure. 1
Risk Stratification: This is a High Thrombotic Risk Patient
Your patient has multiple high-risk features for thromboembolism:
- Valvular atrial fibrillation (not non-valvular)
- Mitral stenosis (specifically mentioned as high-risk condition) 1
- Mitral regurgitation
According to BSG/ESGE guidelines, AF with mitral stenosis is explicitly classified as a HIGH thrombotic risk condition 1. This classification is critical because it determines the management approach.
Dental Extraction: A Low-Risk Bleeding Procedure
Dental extraction is categorized as a low-risk procedure in anticoagulation guidelines 2, 1. For low-risk procedures, the evidence strongly supports continuing warfarin rather than interrupting it.
The Evidence-Based Approach: Continue Warfarin
Pre-Procedure Management:
- Check INR within the week before extraction 1
- If INR is within therapeutic range (2.0-3.0): Continue usual daily warfarin dose and proceed with extraction
- If INR is above therapeutic range but <5: Reduce daily warfarin dose until INR returns to therapeutic range
- If INR >5: Defer the procedure and contact anticoagulation clinic
During the Procedure:
- Perform extraction with meticulous local hemostatic measures
- Use local hemostatic agents (tranexamic acid mouthwash, Surgicel packing, sutures) 3, 4
Post-Procedure:
- Continue warfarin at usual dose - no interruption needed
- Patient should be counseled about slightly increased risk of minor post-extraction bleeding (but NOT major bleeding)
Why NOT Stop Warfarin in This Patient?
The risk-benefit analysis strongly favors continuation:
High thrombotic risk: Your patient's combination of valvular AF and mitral stenosis carries substantial stroke/thromboembolism risk if anticoagulation is interrupted 1, 5
Research evidence supports continuation: Multiple studies demonstrate that continuing warfarin (INR <4.0) for dental extractions results in only minor, easily controlled bleeding without clinically significant complications 6, 3, 4
- One RCT showed 26% minor bleeding with continued warfarin vs 14% with stopped warfarin, but this difference was not statistically significant and all bleeding was controlled with local measures 6
- Another study showed no justification for altering warfarin when INR is 2.0-4.0 with proper local hemostatic measures 3
Bridging therapy is NOT recommended: For high-risk patients undergoing low-risk procedures, bridging with LMWH is specifically NOT indicated and actually increases bleeding risk 1, 7
Critical Pitfall to Avoid
Do NOT use the "high-risk procedure" protocol (stopping warfarin 5 days before and bridging with LMWH). This protocol is reserved for high-bleeding-risk procedures like polypectomy, ERCP with sphincterotomy, or EMR/ESD 1. Dental extraction does not fall into this category.
The common mistake is conflating "high thrombotic risk patient" with "high bleeding risk procedure." Your patient is high thrombotic risk, but the procedure is low bleeding risk - therefore, continue warfarin.
Patient Counseling
Inform the patient that:
- There is a slightly increased risk of minor post-extraction bleeding compared to non-anticoagulated patients 1
- Any bleeding can typically be controlled with local measures at home
- The risk of stopping warfarin (stroke/thromboembolism) outweighs the risk of minor bleeding
- They should contact you immediately if bleeding persists beyond normal pressure application
Summary Algorithm
High thrombotic risk patient (valvular AF + mitral stenosis) + Low bleeding risk procedure (dental extraction) = CONTINUE WARFARIN
- Check INR within 1 week pre-procedure
- Ensure INR 2.0-3.0
- Proceed with extraction using local hemostatic measures
- Continue warfarin throughout
- No bridging therapy needed